文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

精神分裂症认知障碍:病因、发病机制与治疗。

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.

机构信息

Department of Psychiatry, University of Oxford, Oxford, UK.

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

出版信息

Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23.


DOI:10.1038/s41380-023-01949-9
PMID:36690793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10575791/
Abstract

Cognitive deficits are a core feature of schizophrenia, account for much of the impaired functioning associated with the disorder and are not responsive to existing treatments. In this review, we first describe the clinical presentation and natural history of these deficits. We then consider aetiological factors, highlighting how a range of similar genetic and environmental factors are associated with both cognitive function and schizophrenia. We then review the pathophysiological mechanisms thought to underlie cognitive symptoms, including the role of dopamine, cholinergic signalling and the balance between GABAergic interneurons and glutamatergic pyramidal cells. Finally, we review the clinical management of cognitive impairments and candidate novel treatments.

摘要

认知缺陷是精神分裂症的核心特征,导致了与该疾病相关的大部分功能障碍,并且对现有治疗方法没有反应。在这篇综述中,我们首先描述了这些缺陷的临床表现和自然病史。然后,我们考虑了病因因素,强调了一系列类似的遗传和环境因素如何与认知功能和精神分裂症都有关联。接着,我们回顾了被认为是认知症状基础的病理生理机制,包括多巴胺、胆碱能信号传递以及 GABA 能中间神经元和谷氨酸能锥体神经元之间的平衡。最后,我们综述了认知障碍的临床管理和候选新型治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/8cd80477bb79/41380_2023_1949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/7791f96135ef/41380_2023_1949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/4a4e9ea0fec4/41380_2023_1949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/630e4e86fd8e/41380_2023_1949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/8cd80477bb79/41380_2023_1949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/7791f96135ef/41380_2023_1949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/4a4e9ea0fec4/41380_2023_1949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/630e4e86fd8e/41380_2023_1949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/10575791/8cd80477bb79/41380_2023_1949_Fig4_HTML.jpg

相似文献

[1]
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.

Mol Psychiatry. 2023-5

[2]
On the trail of a cognitive enhancer for the treatment of schizophrenia.

Prog Neuropsychopharmacol Biol Psychiatry. 2005-2

[3]
Schizophrenia: Basic and Clinical.

Adv Neurobiol. 2017

[4]
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.

Trends Neurosci. 2011-12-6

[5]
GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Acta Pharmacol Sin. 2018-3-22

[6]
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications.

Neurosci Biobehav Rev. 2023-5

[7]
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.

World Psychiatry. 2020-2

[8]
Neuropsychological and Functional Assessment of Cognitive Impairments in Schizophrenia.

Methods Mol Biol. 2023

[9]
[Cognition, schizophrenia and the effect of antipsychotics].

Encephale. 2006

[10]
Evidence that aetiological risk factors for psychiatric disorders cause distinct patterns of cognitive deficits.

Eur Neuropsychopharmacol. 2013-12-14

引用本文的文献

[1]
Glymphatic system dysfunction in young adults hospitalized for an acute psychotic episode: a preliminary report from a pilot study.

Front Psychiatry. 2025-8-15

[2]
Selective recognition memory impairment in mitochondrial hydroxylase Clk1 mutant mice, rescued by antipsychotics.

Acta Pharmacol Sin. 2025-9-1

[3]
Cognitive impairment and its influencing factors in patients with stable schizophrenia on regular medication: a real-world clinical study.

BMC Psychiatry. 2025-8-26

[4]
Education as a Modifier of Genetic Influence on Cognitive Ability in Older Adults.

Behav Genet. 2025-8-21

[5]
α7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study.

Mol Psychiatry. 2025-8-19

[6]
Disentangling shared and unique brain functional changes associated with clinical severity and cognitive phenotypes in schizophrenia via deep learning.

Commun Biol. 2025-8-13

[7]
MicroRNAs as biomarkers and molecular mediators of cognitive dysfunction in schizophrenia.

J Neural Transm (Vienna). 2025-8-8

[8]
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis.

Psychol Med. 2025-8-8

[9]
Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study.

Front Behav Neurosci. 2025-7-22

[10]
Schizophrenia-associated alterations in fecal mycobiota and systemic immune dysfunction: a cohort study of elderly Chinese patients.

Front Immunol. 2025-7-21

本文引用的文献

[1]
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic.

Trends Pharmacol Sci. 2022-12

[2]
Cognitive trajectories following onset of psychosis: a meta-analysis.

Br J Psychiatry. 2022-12

[3]
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Eur Psychiatry. 2022-9-5

[4]
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data.

Schizophr Bull. 2023-1-3

[5]
The shallow cognitive map hypothesis: A hippocampal framework for thought disorder in schizophrenia.

Schizophrenia (Heidelb). 2022-4-7

[6]
Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis.

Psychol Med. 2022-8

[7]
Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.

Biol Psychiatry. 2022-11-15

[8]
Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models.

Int J Mol Sci. 2022-5-13

[9]
Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.

Transl Psychiatry. 2022-5-12

[10]
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population.

Am J Psychiatry. 2022-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索